Correlation Between Larimar Therapeutics and Senti Biosciences

Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Larimar Therapeutics and Senti Biosciences, you can compare the effects of market volatilities on Larimar Therapeutics and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Senti Biosciences.

Diversification Opportunities for Larimar Therapeutics and Senti Biosciences

0.03

Correlation Coefficient

Larimar Therapeutics  Senti Biosciences

Significant diversification

The 3 months correlation between Larimar and Senti is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Senti Biosciences go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Senti Biosciences

Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.21 times more return on investment than Senti Biosciences. However, Larimar Therapeutics is 1.21 times more volatile than Senti Biosciences. It trades about 0.0 of its potential returns per unit of risk. Senti Biosciences is currently generating about -0.04 per unit of risk. If you would invest  692.00  in Larimar Therapeutics on September 3, 2024 and sell it today you would lose (59.00) from holding Larimar Therapeutics or give up 8.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Larimar Therapeutics  vs.  Senti Biosciences

Larimar Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Larimar Therapeutics is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Senti Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Larimar Therapeutics and Senti Biosciences

The main advantage of trading using opposite Larimar Therapeutics and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.

The idea behind Larimar Therapeutics and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.